This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Hair Disorders  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic

Shannon Routhouska, MD; Anita C. Gilliam, MD, PhD; Paradi Mirmirani, MD

Arch Dermatol. 2006;142:1477-1479.

Background  Hair pigmentation is regulated by several factors including the interaction of the ligand stem cell factor (SCF) with its class III receptor tyrosine kinase, c-kit. An interruption of SCF/c-kit signal transduction results in hair depigmentation.

Observations  A 69-year-old white woman developed hair depigmentation and fine-textured hair while being treated with the phase I chemotherapeutic agent GW786034, a class III/V receptor tyrosine kinase inhibitor. Discontinuation of therapy resulted in a reversal of these hair changes.

Conclusions  Treatment with oral GW786034 resulted in reversible hair depigmentation and change in hair growth rate and texture, which were most likely due to an incomplete inhibition of SCF/c-kit signaling, although the exact mechanism is unknown. It would be intriguing to investigate topical tyrosine kinase inhibitors as a treatment for unwanted body hair.

Author Affiliations: Department of Dermatology, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Stem cell factor/c-Kit signalling in normal and androgenetic alopecia hair follicles
Randall et al.
J Endocrinol 2008;197:11-23.
ABSTRACT | FULL TEXT